Analysis: How A COVID-19 Vaccine Could Cost Americans Dearly
Given the prevailing business-centric model of American drug pricing, a COVID-19 vaccine could be budget breaking, perhaps making it unavailable to many.
Elisabeth Rosenthal
Analysis: One Sure Thing About COVID-19: No Telling How Many People Have It
It has been nearly three months since the first cases of a new coronavirus pneumonia appeared in Wuhan, China, and it is now a global outbreak.
Analysis: Choosing A Plan From The Impossible Health Care Maze
In this highly partisan political moment, there’s one issue that nearly every American can agree on: Our health care system is a mess and in need of a dramatic overhaul.
Analysis: How Your Beloved Hospital Helps To Drive Up Health Care Costs
As voters fume about the high cost of health care, politicians have been targeting two well-deserved villains: pharmaceutical companies, whose prices have risen more than inflation, and ins
Analysis: A Health Care Overhaul Could Kill 2 Million Jobs, And That’s OK
As calls for radical health reform grow louder, many on the right, in the center and in the health care industry are arguing that proposals like “Medicare for All” would cause economic ruin, decimating a sector that represents nearly 20% of our economy.
Analysis: Can States Fix The Disaster Of American Health Care?
Last week, California’s new governor, Gavin Newsom, promised to pursue a smörgåsbord of changes to his state’s health care system: state negotiation of drug prices, a requirement that eve
